中文
About Us
Corporate Overview
Management Team
Board of Directors
Contact Us
Our Focus
Metabolic Diseases
Viral Diseases
Cancer
Exploratory Indications
Products&Pipeline
Pipeline
Products
Clinical Trials
Partnership
Investors
Financials & Filing
Presentation Materials
News
Careers
Investors
Financials & Filing
Presentation Materials
2024
2023
2022
2021
2020
2019
2018
2024
2023
2022
2021
2020
2019
2018
Audit Committee - Terms of Reference
2018-12-27
Nomination Committee - Terms of Reference
2018-12-27
List of Directors and Their Role and Function
2018-12-24
Resignation of Non-Executive Director
2018-12-24
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2018
2018-12-03
Announcement - Inside Information
2018-11-20
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2018
2018-11-02
VOLUNTARY ANNOUNCEMENT - PROPOSED AS PRIORITY REVIEW FOR THE NEW DRUG APPLICATION OF RAVIDASVIR BY CHINA FOOD AND DRUG ADMINISTRATION
2018-10-18
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2018
2018-10-03
Voluntary Announcement - Ganovo Enrolled in the Basic Medical Insurance of Tianjin - Capped Reimbursement-Perpatient Pilot Program
2018-09-26
1
2
3
4
»